Bala R. Attili

BioPharmaceuticals R&D, AstraZeneca
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 12, 2024

Translational Preclinical PET Imaging and Metabolic Evaluation of a New Cannabinoid 2 Receptor (CB2R) Radioligand, (Z)-N-(3-(2-(2-[18F]Fluoroethoxy)ethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethylcyclopropane-1-carboxamide.

Translational Preclinical PET Imaging and Metabolic Evaluation of a New Cannabinoid 2 Receptor (CB2R) Radioligand, (Z)-N-(3-(2-(2-[18F]Fluoroethoxy)ethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethylcyclopropane-1-carboxamide.

Journal: ACS pharmacology & translational science
Published: June 07, 2024

Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am.

Preclinical PET Imaging of Tumor Cell Death following Therapy Using Gallium-68-Labeled C2Am.

Journal: Cancers
Published: November 30, 2022

In Vivo Cell Tracking Using PET: Opportunities and Challenges for Clinical Translation in Oncology.

In Vivo Cell Tracking Using PET: Opportunities and Challenges for Clinical Translation in Oncology.

Journal: Cancers
Published: June 30, 2021

3D printing 18F radioactive phantoms for PET imaging.

3D printing 18F radioactive phantoms for PET imaging.

Journal: EJNMMI physics
Published: December 23, 2020

The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST).

The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST).

Journal: EJNMMI research
Published: October 27, 2020

18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography.

18F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography.

Journal: EJNMMI research
Published: July 27, 2020

The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.

The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.

Journal: Nuclear medicine and biology
Published: May 25, 2020

Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model.

Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model.

Journal: Nuclear medicine and biology
Published: April 07, 2020

Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI.

Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI.

Journal: EJNMMI research
Published: March 19, 2020

Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications.

Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications.

Journal: Drug discovery today
Published: August 16, 2019

TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study.

TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 03, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026